Publications by authors named "M Heit"

Objective: To describe composite 30-day postoperative complication rates among patients undergoing hysterectomy during the coronavirus disease 2019 (COVID-19) pandemic and to determine baseline and postoperative mental health symptoms, levels of social support, and socioeconomic status and their association with hysterectomy outcomes.

Methods: This multicenter prospective cohort study at eight centers across the United States enrolled patients who underwent minimally invasive hysterectomy for benign indications during the COVID-19 pandemic. Patients completed preoperative and postoperative surveys assessing mental health (PHQ-9 [Patient Health Questionnaire]), social support (MOS-SS [Medical Outcomes Study Social Support Survey]), and socioeconomic status (Hollingshead Index [Hollingshead Four Factor Index of Socioeconomic Status]).

View Article and Find Full Text PDF
Article Synopsis
  • - The study evaluated the safety and effectiveness of iltamiocel, an autologous muscle cell therapy, for treating stress urinary incontinence (SUI) in women, comparing it to a placebo group.
  • - Results showed no significant difference in the overall reduction of stress incontinence episodes between groups, but iltamiocel was more effective in women with previous SUI surgeries, indicating potential benefits for this specific population.
  • - While the primary endpoint was not achieved, iltamiocel therapy was deemed safe, suggesting further research is needed for women with prior SUI surgery who lack effective treatment options.
View Article and Find Full Text PDF

Importance: Providing recovery expectations for prolapse surgery is an important part of patient counseling and aids in patient-centered decision making.

Objectives: The purpose of this study was to determine if postoperative recovery from minimally invasive sacrocolpopexy (MISCP) is noninferior to that of native tissue repair.

Study Design: Recovery at 2 and 6 weeks was quantified using the Postdischarge Surgical Recovery 13 scale, where higher scores indicate greater patient-perceived recovery.

View Article and Find Full Text PDF
Article Synopsis
  • - Oxaliplatin is a chemotherapy drug used to treat gastrointestinal cancers, but it can cause chemotherapy-induced peripheral neuropathy (CIPN), limiting treatment effectiveness.
  • - A pilot study is being conducted with 56 patients to investigate if acupuncture and acupressure can reduce CIPN and other chemotherapy-related side effects during treatment with 5-fluorouracil (5-FU) and oxaliplatin.
  • - Participants are randomly assigned to receive either acupuncture with self-acupressure or standard treatment, and various symptoms and side effects will be assessed over three months to evaluate the effectiveness and feasibility of this approach.
View Article and Find Full Text PDF